Cover Image
市場調查報告書

高內涵篩選 (HCS) 的全球市場:2015∼2019年

Global High Content Screening (HCS) Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 334060
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
高內涵篩選 (HCS) 的全球市場:2015∼2019年 Global High Content Screening (HCS) Market 2015-2019
出版日期: 2015年07月01日 內容資訊: 英文 76 Pages
簡介

高內涵篩選 (HCS) 技術在單一細胞層級進行影像為基礎的多重參數分析的技術,當初是在開發藥劑中未了補充生物學的高通量篩檢而開發。HCS分析細胞樣品的表現型的變化。全球高內涵篩選市場,2014∼2019年預計以年複合成長率11.53%擴大。

本報告提供全球高內涵篩選 (HCS) 市場相關詳細分析、市場趨勢與2015∼2019年的成長預測、各終端用戶、各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 簡稱清單

第3章 本報告的範圍

第4章 市場調查方法

第5章 簡介

第6章 重要趨勢

第7章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 各終端用戶市場區隔

第9章 各地區市場區隔

  • 各地區市場市場區隔
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 購買標準

第11章 市場成長的促進要素

第12章 促進要素與其影響

第13章 市場課題

第14章 促進要素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 供應商環境

  • 競爭模式
  • 市場佔有率調查:2014年
  • 其他具未來性的供應商

第18章 主要供應商調查

  • Becton, Dickinson and Co.
  • GE Healthcare
  • Danaher
  • PerkinElmer
  • Thermo Fisher Scientific

第19章 本系列的其他報告

圖表

目錄
Product Code: IRTNTR6483

About HCS

High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.

Technavio's analysts forecast the global HCS market to grow at a CAGR of 11.53% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global HCS market for the period 2015-2019. The market can be segmented into three customer segments: Pharmaceutical and biotechnology companies, academia and research institutes, and contract research organizations.

Technavio's report, Global HCS Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global HCS market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Becton, Dickinson and Company
  • GE Healthcare
  • Danaher
  • PerkinElmer
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Blue Sky Bioservices
  • Cell Signaling Technology
  • Charles River Laboratories International
  • Cytoo
  • EMD Millipore
  • Evotec
  • Fluofarma
  • Genedata
  • Imagen Biotech
  • Thorlabs
  • Tecan
  • Vala Sciences
  • Wako Automation
  • Yokogawa

Key Market Driver

  • Growing Importance of High Content Screening in Therapeutics
  • For a full, detailed list, view our report

Key Market Challenge

  • Handling Large Amount of Data
  • For a full, detailed list, view our report

Key Market Trend

  • Advances in Personalized Medicines
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Key Developments

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by End-User

09. Geographical Segmentation

  • 09.1. Segmentation of Global HCS Market by Region
  • 09.2. HCS Market in Americas
    • 09.2.1. Market Size and Forecast
  • 09.3. HCS Market in EMEA
    • 09.3.1. Market Size and Forecast
  • 09.4. HCS Market in APAC
    • 09.4.1. Market Size and Forecast

10. Buying Criteria

11. Market Drivers

12. Drivers and Their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and Their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2014
    • 17.2.1. BD
    • 17.2.2. GE Healthcare
    • 17.2.3. Molecular Devices (Subsidiary of Danaher)
    • 17.2.4. PerkinElmer
    • 17.2.5. Thermo Fisher Scientific
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Becton, Dickinson and Co.
    • 18.1.1. Key Facts
    • 18.1.2. Business Description
    • 18.1.3. Business Segmentation
    • 18.1.4. Revenue Segmentation by Business
    • 18.1.5. Segmental Revenue Comparison 2013 and 2012
    • 18.1.6. Revenue Segmentation by Region
    • 18.1.7. Business Strategy
    • 18.1.8. Key Developments
    • 18.1.9. SWOT Analysis
  • 18.2. GE Healthcare
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Strategy
    • 18.2.5. Key Developments
    • 18.2.6. SWOT Analysis
  • 18.3. Danaher
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation
    • 18.3.4. Revenue by Business Segmentation
    • 18.3.5. Revenue Comparison 2012 and 2013
    • 18.3.6. Segmentation by Region
    • 18.3.7. Business Strategy
    • 18.3.8. Key Information
    • 18.3.9. SWOT Analysis
  • 18.4. PerkinElmer
    • 18.4.1. Key Facts
    • 18.4.2. Business Description
    • 18.4.3. Business Segmentation
    • 18.4.4. Business Strategy
    • 18.4.5. Revenue Segmentation by Business
    • 18.4.6. Key Developments
    • 18.4.7. SWOT Analysis
  • 18.5. Thermo Fisher Scientific
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Segmentation by Revenue 2014
    • 18.5.4. Business Segmentation by Revenue 2013 and 2014
    • 18.5.5. Geographical Segmentation by Revenue 2014
    • 18.5.6. Business Strategy
    • 18.5.7. Recent Developments
    • 18.5.8. SWOT Analysis

19. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Advantages of HCS over Traditional Technologies
  • Exhibit 3: Global HCS Market 2014-2019 ($ millions)
  • Exhibit 4: Segmentation of Global HCS Market by End-User
  • Exhibit 5: Segmentation of Global HCS Market by End-User 2014
  • Exhibit 6: Segmentation of Global HCS Market by Region 2014
  • Exhibit 7: HCS Market in Americas 2014-2019 ($ millions)
  • Exhibit 8: HCS Market in EMEA 2014-2019 ($ millions)
  • Exhibit 9: HCS Market in APAC 2014-2019 ($ millions)
  • Exhibit 10: Pros and Cons of IN Cell Analyzer 2000
  • Exhibit 11: Pros and Cons of ImageXpress Micro Widefield (Standard) and Image Xpress Micro Widefield XL
  • Exhibit 12: Pros and Cons of Opera
  • Exhibit 13: Pros and Cons of Operetta
  • Exhibit 14: Product Categorization of Becton, Dickinson and Co.
  • Exhibit 15: Revenue Segmentation of Becton, Dickinson and Co. 2013
  • Exhibit 16: Revenue Comparison ($ millions)
  • Exhibit 17: Revenue Segmentation of Becton, Dickinson and Co. by Region 2013
  • Exhibit 18: GE Healthcare: Business Segmentation 2013
  • Exhibit 19: Danaher: Business Segmentation
  • Exhibit 20: Danaher: Business Segmentation 2013
  • Exhibit 21: Danaher: Revenue by Business Segmentation 2012 and 2013 ($ millions)
  • Exhibit 22: Danaher: Revenue by Geographical Segmentation 2013
  • Exhibit 23: PerkinElmer: Business Segmentation 2013
  • Exhibit 24: PerkinElmer: Revenue Segmentation 2013
  • Exhibit 25: PerkinElmer: Revenue by Business Segments 2013 and 2012 ($ billions)
  • Exhibit 26: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
  • Exhibit 27: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billions)
  • Exhibit 28: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014
Back to Top